Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Biobin Cytarabine Injection
Biobin, offered by Lexaro Healthcare, contains Cytarabine in an injectable formulation. Each dose is meticulously crafted to ensure high quality and efficacy.
Uses of Biobin Cytarabine Injection
Biobin is primarily prescribed for the treatment of certain types of leukemia, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). It is also used in the treatment of chronic myeloid leukemia (CML) and non-Hodgkin's lymphoma.
Benefits of Biobin Cytarabine Injection
Effective in treating various forms of leukemia and lymphomas.
Rapidly targets and eliminates cancerous cells, promoting remission.
Can be used in combination with other chemotherapeutic agents for enhanced efficacy.
Well-tolerated with a favorable safety profile when used under medical supervision.
Mechanism of Action of Biobin Cytarabine Injection
Cytarabine is an antimetabolite that interferes with DNA synthesis. It gets incorporated into the DNA of rapidly dividing cancer cells, inhibiting their replication and leading to cell death. By targeting the DNA synthesis process, Biobin effectively reduces the proliferation of cancerous cells.